Cargando…
COX6B2 drives metabolic reprogramming toward oxidative phosphorylation to promote metastasis in pancreatic ductal cancer cells
Pancreatic ductal adenocarcinoma (PDAC) is an aggressive cancer type with poor prognosis due to its high metastatic potential, however, the role of metabolic reprogramming in the metastasis of PDAC cell is not known. Here, we report that COX6B2 drive metastasis but not cancer cell proliferation in P...
Autores principales: | Nie, Ke, Li, Jin, He, Xujun, Wang, Yuqing, Zhao, Qiongya, Du, Miaomiao, Sun, Hongwei, Wang, Jinjing, Lyu, Jianxin, Fang, Hezhi, Jin, Liqin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7229118/ https://www.ncbi.nlm.nih.gov/pubmed/32415061 http://dx.doi.org/10.1038/s41389-020-0231-2 |
Ejemplares similares
-
4-Hydroxyphenylpyruvate Dioxygenase-Like Protein Promotes Pancreatic Cancer Cell Progression and Is Associated With Glutamine-Mediated Redox Balance
por: Ye, Xianglai, et al.
Publicado: (2021) -
Neurogenin3 phosphorylation controls reprogramming efficiency of pancreatic ductal organoids into endocrine cells
por: Azzarelli, Roberta, et al.
Publicado: (2018) -
Oncogenic HSP60 regulates mitochondrial oxidative phosphorylation to support Erk1/2 activation during pancreatic cancer cell growth
por: Zhou, Chao, et al.
Publicado: (2018) -
TP63-Mediated Enhancer Reprogramming Drives the Squamous Subtype of Pancreatic Ductal Adenocarcinoma
por: Somerville, Tim D.D., et al.
Publicado: (2018) -
Mitochondrial supercomplex assembly regulates metabolic features and glutamine dependency in mammalian cells
por: Zhang, Kun, et al.
Publicado: (2023)